| Akcje zaległe | 9,930,329 shares |
| Akcje insidera | 1 198 185 shares |
| Własność insidera | 12,07 % |
| Insiderzy ogółem | 37 |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
509 out of 10948
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
262 out of 10786
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia SCYNEXIS, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
|
Alta Biopharma Management Ii Llc
10% Owner -
|
45 736 | 5 082 | |
|
Alta Biopharma Partners Ii Lp
10% Owner -
|
45 736 | 5 082 | |
|
Alta Embarcadero Biopharma Partners Ii Llc
10% Owner -
|
45 736 | 5 082 | |
| Armando Anido Director - [D] | 71 000 | 8 875 | |
| Gonzalez David Angulo Chief Executive Officer, Director - [D] [O] | 1 357 126 | 169 641 | |
| Laurent Arthaud Director - [D] | 4 507 | 501 | |
|
Farah Champsi
10% Owner -
|
45 736 | 5 082 | |
| Mounia Chaoui | 3 480 | ||
| Christine Coyne Chief Commercial Officer - [O] | 58 200 | 7 275 | |
|
Joseph Edelman
10% Owner -
|
2 400 000 | 300 000 | |
|
F.C.P.R. Genavent
10% Owner -
|
237 598 | 26 400 | |
|
FCPR Biotechnology Fund
10% Owner -
|
295 077 | 32 786 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Eric Francois Chief Financial Officer - [O] | 11 732 | 1 466 | |
| Steven C Gilman Director - [D] | 70 000 | 8 750 | |
| Michael C Garrett Vice President - [O] | 6 216 | 691 | |
| Ann Hanham Director - [D] | 69 622 | 8 703 | |
| David C Hastings Director - [D] | 69 183 | 8 648 | |
| Pamela J Kirby Director - [D] | 25 590 | 2 843 | |
| Patrick Langlois Director - [D] | 10 503 | 1 167 | |
| Guy Macdonald Director - [D] | 78 000 | 9 750 | |
| Patrick Machado Director - [D] | 60 000 | 6 667 | |
| ivor Macleod Chief Financial Officer - [O] | 398 529 | 49 816 | |
| Marion McCourt | 9 217 | ||
| Jean-Yves Nothias Director - [D] | 295 077 | 32 786 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Osborne, Jr. Charles F Chief Financial Officer - [O] | 17 900 | 1 989 | |
| Edward Penhoet | 8 800 | ||
|
Perceptive Advisors Llc
10% Owner -
|
2 400 000 | 300 000 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
1 800 000 | 300 000 | |
| Eileen Pruette | 25 230 | ||
| Yves J Ribeill President and CEO, Director - [D] [O] | 1 190 | 132 | |
| Carole Sable | 26 970 | ||
|
Sanofi
10% Owner -
|
3 177 057 | 353 006 | |
| Scott Sukenick Chief Legal Officer - [O] | 574 539 | 71 817 | |
| Marco Taglietti Chief Executive Officer, Director - [D] [O] | 272 068 | 34 008 | |
| Brian Philippe Tinmouth Director - [D] | 74 000 | 9 250 | |
|
Capital II Ventech
10% Owner -
|
414 211 | 46 023 | |
| Jonathan Sears Woodall Interim Chief FinancialOfficer - [O] | 1 000 | 111 |
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w SCYX / SCYNEXIS, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w SCYX / SCYNEXIS, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | 2026-04-01 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 108 695 | 1 357 126 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Macleod ivor | SCYX | Common Stock | D | 129 833 | 398 529 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Sukenick Scott | SCYX | Common Stock | D | 129 833 | 574 539 | ||||||
| 2026-02-02 | 2026-01-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 391 333 | 1 244 431 | ||||||
| 2025-10-21 | 2025-10-17 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 0,7600 | 32 500 | 25 | 853 098 | ||||
| 2025-06-30 | 2025-06-26 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23 000 | 74 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23 000 | 78 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23 000 | 69 183 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23 000 | 69 622 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | GILMAN STEVEN C | SCYX | Common stock | D | 23 000 | 70 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23 000 | 71 000 | ||||||
| 2025-04-10 | 2025-04-09 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 0,8400 | 23 000 | 19 | 816 598 | ||||
| 2025-03-20 | 2025-03-20 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,0500 | 13 800 | 14 | 793 598 | ||||
| 2025-03-20 | 2025-03-19 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,0700 | 5 000 | 5 | 779 798 | ||||
| 2025-01-27 | 2025-01-23 | 4 | Sukenick Scott | SCYX | Common Stock | D | 92 511 | 436 706 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Macleod ivor | SCYX | Common Stock | D | 92 511 | 260 696 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 262 927 | 770 798 | ||||||
| 2024-09-16 | 2024-09-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3700 | 20 000 | 27 | 507 871 | ||||
| 2024-06-21 | 2024-06-20 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23 000 | 55 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23 000 | 46 183 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 23 000 | 47 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23 000 | 51 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23 000 | 48 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23 000 | 46 622 | ||||||
| 2024-02-16 | 2024-02-16 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1,6300 | -15 179 | -25 | 336 195 | ||||
| 2024-01-30 | 2024-01-26 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 290 590 | 479 871 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Macleod ivor | SCYX | Common Stock | D | 143 675 | 160 185 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 143 675 | 351 374 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10 000 | 23 183 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10 000 | 23 622 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10 000 | 24 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10 000 | 25 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10 000 | 28 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10 000 | 32 000 | ||||||
| 2023-05-17 | 2023-05-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 50 000 | 203 599 | ||||||
| 2023-01-31 | 2023-01-27 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100 000 | 153 599 | ||||||
| 2023-01-03 | 2023-01-01 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 110 000 | 185 181 | ||||||
| 2022-10-26 | 2022-10-24 | 4 | Macleod ivor | SCYX | Common Stock | D | 15 000 | 15 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10 000 | 18 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10 000 | 22 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10 000 | 13 183 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10 000 | 13 622 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10 000 | 14 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10 000 | 15 000 | ||||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 3,45 | 75 000 | 75 000 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,0000 | 75 000 | 225 | 272 068 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 3,45 | 3 500 | 3 500 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 3,0000 | 3 500 | 10 | 53 499 | ||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 4,60 | 75 000 | 75 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Common Stock | D | 43 200 | 58 200 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 4,60 | 70 000 | 70 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Common Stock | D | 40 700 | 49 899 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 4,60 | 85 000 | 85 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 51 100 | 74 981 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 4,60 | 232 000 | 232 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Common Stock | D | 87 200 | 196 968 | ||||||
| 2021-06-21 | 2021-06-16 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 6,50 | 125 000 | 125 000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Common Stock | D | 15 000 | 15 000 | ||||||
| 2021-03-31 | 2020-07-06 | 4/A | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 7,47 | 170 000 | 170 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 7,47 | 40 000 | 40 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 7,47 | 65 000 | 65 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 7,47 | 65 000 | 65 000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8,9500 | -33 849 | -303 | 1 800 000 | ||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8,1600 | -285 151 | -2 327 | 1 833 849 | ||||
| 2021-01-26 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7,3800 | -95 000 | -701 | 2 120 000 | ||||
| 2021-01-26 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7,4300 | -185 000 | -1 375 | 2 215 000 | ||||
| 2021-01-26 | 3 | EDELMAN JOSEPH | SCYX | Common Stock | I | 2 400 000 | ||||||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 7,33 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 8,25 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 6,2500 | 8 000 | 50 | 8 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 8,25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 7,33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6,2500 | 1 600 | 10 | 9 099 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 8,25 | 20 000 | 20 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 7,33 | 20 000 | 20 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,2500 | 40 000 | 250 | 109 668 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 8,25 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 7,33 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock | D | 6,2500 | 8 000 | 50 | 12 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 8,25 | 1 600 | 1 600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 7,33 | 1 600 | 1 600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock | D | 6,2500 | 3 200 | 20 | 3 622 | ||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 8,25 | 2 000 | 2 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 7,33 | 2 000 | 2 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 6,2500 | 4 000 | 25 | 4 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 8,25 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 7,33 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock | D | 6,2500 | 600 | 4 | 11 732 | ||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 7,33 | 2 500 | 2 500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 8,25 | 2 500 | 2 500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 6,2500 | 5 000 | 31 | 5 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 7,33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 8,25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6,2500 | 1 600 | 10 | 23 780 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6,8100 | -4 323 | -29 | 22 180 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 9,8000 | -1 175 | -12 | 26 303 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Francois Eric | SCYX | Common Stock | D | 6,8100 | -3 480 | -24 | 11 132 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 9,8000 | -979 | -10 | 14 412 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6,8100 | -2 613 | -18 | 7 499 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 9,8000 | -783 | -8 | 9 912 | ||||
| 2020-07-08 | 2020-07-06 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 0,86 | 900 000 | 900 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 0,86 | 450 000 | 450 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 0,86 | 375 000 | 375 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 0,86 | 250 000 | 250 000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (right to buy) | D | 0,73 | 70 000 | 70 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1,10 | 166 667 | 166 667 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0,9000 | 166 667 | 150 | 693 682 | ||||
| 2019-08-22 | 2019-08-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,1100 | 9 500 | 11 | 526 015 | ||||
| 2019-08-22 | 2019-08-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,1100 | 500 | 1 | 516 515 | ||||
| 2019-08-19 | 2019-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,0100 | 10 015 | 10 | 516 015 | ||||
| 2019-06-20 | 2019-06-18 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-04-18 | 2019-04-17 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6300 | 25 000 | 41 | 506 000 | ||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 1,38 | 150 000 | 150 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 150 000 | 271 790 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 1,38 | 125 000 | 125 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 125 000 | 149 917 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 1,38 | 100 000 | 100 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100 000 | 102 959 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 1,38 | 700 000 | 700 000 | |||||
| 2019-01-23 | 2019-01-21 | 4 | ANIDO ARMANDO | SCYX | Stock Option (right to buy) | D | 0,74 | 70 000 | 70 000 | |||||
| 2019-01-14 | 2019-01-10 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0,6900 | 25 000 | 17 | 480 000 | ||||
| 2019-01-04 | 2019-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-02 | 2018-12-31 | 4 | Angulo Gonzalez David | SCYX | Common stock | D | 0,4959 | 12 000 | 6 | 121 790 | ||||
| 2019-01-02 | 2018-12-31 | 4 | Taglietti Marco | SCYX | Common stock | D | 0,4600 | 25 000 | 12 | 455 000 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,22 | 0,7900 | 21 595 | 17 | 21 595 | |||
| 2018-09-10 | 2018-09-06 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,2700 | 7 000 | 9 | 108 790 | ||||
| 2018-08-27 | 2018-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,2900 | 25 000 | 32 | 429 000 | ||||
| 2018-07-03 | 2018-07-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,69 | 1,1000 | 15 589 | 17 | 15 589 | |||
| 2018-07-03 | 2018-07-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1,69 | 1,1000 | 9 217 | 10 | 9 217 | |||
| 2018-04-04 | 2018-04-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,32 | 0,8600 | 19 959 | 17 | 19 959 | |||
| 2018-04-04 | 2018-04-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1,32 | 0,8600 | 11 800 | 10 | 11 800 | |||
| 2018-04-02 | 2018-03-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3600 | 6 000 | 8 | 101 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3900 | 7 000 | 10 | 95 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 45 000 | 45 000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 75 000 | 75 000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6900 | 100 000 | 169 | 404 000 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 1 331 | 1 331 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 2 219 | 2 219 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1,6900 | 2 959 | 5 | 2 959 | ||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 5 325 | 5 325 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 8 875 | 8 875 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1,6900 | 11 834 | 20 | 31 834 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 6 655 | 6 655 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 11 092 | 11 092 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,6900 | 14 790 | 25 | 88 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 2 662 | 2 662 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 4 437 | 4 437 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock | D | 1,6900 | 5 917 | 10 | 24 917 | ||||
| 2018-02-13 | 2018-02-09 | 4 | Sukenick Scott | SCYX | Stock option (right to buy) | D | 1,69 | 15 000 | 15 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Taglietti Marco | SCYX | Stock option (right to buy) | D | 1,69 | 375 000 | 375 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Francois Eric | SCYX | Stock option (right to buy) | D | 1,69 | 150 000 | 150 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Angulo Gonzalez David | SCYX | Stock option (right to buy) | D | 1,69 | 200 000 | 200 000 | |||||
| 2018-01-04 | 2018-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,28 | 1,4800 | 11 555 | 17 | 11 555 | |||
| 2018-01-04 | 2018-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,28 | 1,4800 | 6 831 | 10 | 6 831 | |||
| 2017-11-17 | 2017-11-15 | 4 | Sukenick Scott | SCYX | Stock Option (right to buy) | D | 1,75 | 160 000 | 160 000 | |||||
| 2017-10-04 | 2017-10-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,46 | 1 807 | 1 807 | |||||
| 2017-10-04 | 2017-10-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,46 | 10 709 | 10 709 | |||||
| 2017-10-04 | 2017-10-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,46 | 6 332 | 6 332 | |||||
| 2017-09-25 | 2017-09-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2,2300 | 10 000 | 22 | 303 000 | ||||
| 2017-08-24 | 2017-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,8500 | 4 993 | 9 | 292 000 | ||||
| 2017-08-24 | 2017-08-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6100 | 7 | 0 | 287 007 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6100 | 10 000 | 16 | 287 000 | ||||
| 2017-08-14 | 2017-08-11 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,5500 | 10 000 | 16 | 72 000 | ||||
| 2017-07-05 | 2017-07-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 1,83 | 2 430 | 2 430 | |||||
| 2017-07-05 | 2017-07-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 1,83 | 14 396 | 14 396 | |||||
| 2017-07-05 | 2017-07-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 1,83 | 8 511 | 8 511 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1,7500 | 20 000 | 35 | 20 000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,7000 | 15 000 | 26 | 62 000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6900 | 25 000 | 42 | 277 000 | ||||
| 2017-04-04 | 2017-04-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,65 | 9 941 | 9 941 | |||||
| 2017-04-04 | 2017-04-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,65 | 5 878 | 5 878 | |||||
| 2017-04-04 | 2017-04-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,65 | 1 678 | 1 678 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 3,02 | 360 000 | 360 000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 3,02 | 140 000 | 140 000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 3,02 | 100 000 | 100 000 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3,15 | 34 144 | 34 144 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3,15 | 4 274 | 4 274 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,40 | 7 749 | 7 749 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,40 | 1 308 | 1 308 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2016-12-22 | 2016-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,3000 | 25 000 | 82 | 251 000 | ||||
| 2016-12-19 | 2016-12-16 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 3,2500 | 4 000 | 13 | 46 000 | ||||
| 2016-10-04 | 2016-10-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4,55 | 6 255 | 6 255 | |||||
| 2016-10-04 | 2016-10-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4,55 | 977 | 977 | |||||
| 2016-09-16 | 2016-09-15 | 4 | Machado Patrick | SCYX | Common Stock | D | 2,9400 | 40 000 | 118 | 60 000 | ||||
| 2016-07-11 | 2016-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,19 | 12 996 | 12 996 | |||||
| 2016-07-11 | 2016-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,19 | 2 030 | 2 030 | |||||
| 2016-07-01 | 2016-06-30 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2,2300 | 32 150 | 72 | 41 000 | ||||
| 2016-07-01 | 2016-06-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2,1800 | 4 800 | 10 | 8 850 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 18 000 | 0 | 18 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock | D | 2,3900 | 40 000 | 96 | 40 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 9 000 | 0 | 9 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock | D | 2,3900 | 20 000 | 48 | 20 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 45 000 | 1 | 45 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2,3900 | 100 000 | 239 | 225 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 6 750 | 0 | 6 750 | |||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock | D | 2,3900 | 15 000 | 36 | 15 000 | ||||
| 2016-06-06 | 2016-06-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-05-27 | 2016-05-25 | 4 | HANHAM ANN | SCYX | Common Stock | D | 3,6400 | 4 225 | 15 | 4 225 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,2600 | 5 754 | 19 | 124 754 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,2000 | 246 | 1 | 125 000 | ||||
| 2016-05-25 | 2016-05-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,3700 | 5 500 | 19 | 119 000 | ||||
| 2016-05-24 | 2016-05-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,1500 | 3 000 | 9 | 113 500 | ||||
| 2016-05-24 | 2016-05-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,1400 | 4 500 | 14 | 110 500 | ||||
| 2016-05-20 | 2016-05-19 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,0700 | 6 000 | 18 | 106 000 | ||||
| 2016-04-05 | 3/A | Angulo Gonzalez David | SCYX | Common Stock | D | 50 | ||||||||
| 2016-04-05 | 2016-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4,05 | 7 027 | 7 027 | |||||
| 2016-04-05 | 2016-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4,05 | 1 098 | 1 098 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 4,05 | 185 000 | 185 000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 4,05 | 70 000 | 70 000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 4,05 | 20 000 | 20 000 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6,10 | 4 666 | 4 666 | |||||
| 2016-01-06 | 2016-01-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6,10 | 729 | 729 | |||||
| 2015-11-24 | 2015-11-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,8000 | 7 733 | 53 | 100 000 | ||||
| 2015-11-24 | 2015-11-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,7900 | 15 000 | 102 | 92 267 | ||||
| 2015-11-03 | 2015-11-02 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 6,53 | 100 000 | 100 000 | |||||
| 2015-10-05 | 2015-10-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6,64 | 670 | 670 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 6,64 | 1 607 | 1 607 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6,64 | 4 286 | 4 286 | |||||
| 2015-09-28 | 2015-09-24 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 6,89 | 11 700 | 11 700 | |||||
| 2015-09-28 | 2015-09-24 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 6,89 | 11 700 | 11 700 | |||||
| 2015-09-18 | 2015-09-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 7,0000 | 3 000 | 21 | 3 000 | ||||
| 2015-09-02 | 2015-08-31 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,8200 | 25 000 | 196 | 77 267 | ||||
| 2015-08-31 | 2015-08-28 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1500 | 400 | 3 | 52 267 | ||||
| 2015-08-31 | 2015-08-27 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,0700 | 1 867 | 13 | 51 867 | ||||
| 2015-08-27 | 2015-08-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,9800 | 25 000 | 174 | 50 000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1500 | 20 000 | 143 | 25 000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1600 | 5 000 | 36 | 5 000 | ||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1 000 | ||||||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1 000 | ||||||||
| 2015-07-24 | 2015-07-22 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8,64 | 8 800 | 8 800 | |||||
| 2015-07-06 | 2015-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,86 | 502 | 502 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,86 | 2 974 | 2 974 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,86 | 1 465 | 1 465 | |||||
| 2015-06-05 | 2015-06-04 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 8,65 | 125 000 | 125 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,76 | 1 976 | 1 976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,76 | 1 976 | 1 976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,76 | 1 207 | 1 207 | |||||
| 2015-04-03 | 2015-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,76 | 554 | 544 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 8,76 | 330 000 | 330 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,76 | 1 690 | 1 690 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8,76 | 50 000 | 50 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 8,76 | 9 541 | 9 541 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10,00 | 486 | 486 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10,00 | 7 830 | 7 830 | |||||
| 2015-01-06 | 2015-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 9,96 | 2 047 | 2 047 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 9,96 | 869 | 869 | |||||
| 2015-01-06 | 2015-01-02 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 9,96 | 1 738 | 1 738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 9,96 | 1 660 | 1 660 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 9,96 | 1 738 | 1 738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 9,96 | 1 274 | 1 274 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10,81 | 1 530 | 1 530 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10,81 | 7 830 | 7 830 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 10,81 | 7 830 | 7 830 | |||||
| 2014-10-02 | 2014-10-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 7,70 | 2 048 | 2 048 | |||||
| 2014-10-02 | 2014-10-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 7,70 | 1 648 | 1 648 | |||||
| 2014-10-02 | 2014-07-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,03 | 1 964 | 1 964 | |||||
| 2014-10-02 | 2014-07-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,03 | 1 581 | 1 581 | |||||
| 2014-10-02 | 2014-10-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 7,70 | 2 248 | 2 248 | |||||
| 2014-10-02 | 2014-07-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,03 | 2 155 | 2 155 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9,64 | 25 230 | 25 230 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 24,48 | -9 803 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9,64 | 9 803 | 9 803 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 187 052 | 187 052 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 30,60 | -1 960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 1 960 | 1 960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25,91 | -2 941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | -2 941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 2 941 | 2 941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 2 941 | 2 941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25,50 | -3 676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | -3 676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 3 676 | 3 676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 3 676 | 3 676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | -931 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 931 | 931 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | -7 352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | -7 352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 7 352 | 7 352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 7 352 | 7 352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 57 420 | 57 420 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 30,60 | -833 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 833 | 833 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25,91 | -1 470 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 470 | 1 470 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25,50 | -1 225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | -1 225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 225 | 1 225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 225 | 1 225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | -808 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 808 | 808 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | -490 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 490 | 490 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | -934 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 934 | 934 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | -960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 960 | 960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9,64 | 26 970 | 26 970 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 10,00 | -46 636 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9,64 | 46 636 | 46 636 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,73 | 1 321 | 1 321 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,73 | 5 220 | 5 220 | |||||
| 2014-06-13 | 2014-06-11 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,73 | 1 204 | 1 204 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,73 | 969 | 969 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Chaoui Mounia | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Arthaud Laurent | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1 805 363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3 177 057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1 725 808 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3 177 057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1 805 363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1 725 808 | ||||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-2 Preferred Stock | D | -341 456 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-1 Preferred Stock | D | -955 215 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series C Preferred Stock | D | -342 726 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series B Preferred Stock | D | -188 679 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -3 501 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -5 251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -5 251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 10,0000 | 10 000 | 100 | 237 598 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 16 738 | 227 598 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 46 824 | 210 860 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 96 921 | 164 036 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 53 112 | 67 115 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 3 501 | 1 | 14 003 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 3/A | Arthaud Laurent By wife | SCYX | Common Stock | I | 3 738 | ||||||||
| 2014-05-08 | 3/A | Arthaud Laurent | SCYX | Common Stock | D | 735 | ||||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Series D-2 Preferred Stock | D | -260 000 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -12 745 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 12 745 | 25 590 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 0,2000 | 12 745 | 3 | 12 745 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-2 Preferred Stock | I | -53 915 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-1 Preferred Stock | I | -37 702 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series C Preferred Stock | I | -20 975 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -3 033 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-2 Preferred Stock | D | -1 417 315 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-1 Preferred Stock | D | -1 024 876 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series C Preferred Stock | D | -570 159 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -82 454 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -4 551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -4 551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 10,0000 | 31 934 | 319 | 45 736 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 2 642 | 13 802 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 1 848 | 11 160 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 5 931 | 9 312 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 3 033 | 1 | 3 381 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 10,0000 | 868 066 | 8 681 | 1 240 575 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 69 476 | 372 509 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 50 239 | 303 033 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 161 238 | 252 794 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 82 454 | 16 | 91 556 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 4 551 | 1 | 9 102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 4 551 | 1 | 9 102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Series D-2 Preferred Stock | I | -107 142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 5 252 | 10 503 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 26 785 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | I | -623 880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | I | -863 672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | I | -313 996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | I | -166 482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -25 998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 10,0000 | 50 000 | 500 | 295 077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 30 582 | 245 077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 42 336 | 214 495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 88 796 | 172 159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 46 863 | 83 363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 25 998 | 5 | 36 500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | D | -623 880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | D | -863 672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | D | -313 996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | D | -166 482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -25 998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 10,0000 | 50 000 | 500 | 295 077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 30 582 | 245 077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 42 336 | 214 495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 88 796 | 172 159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 46 863 | 83 363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 25 998 | 5 | 36 500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Series D-2 Preferred Stock | D | -12 142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -595 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 595 | 1 190 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 0,2000 | 595 | 0 | 595 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-2 Preferred Stock | I | -1 665 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-1 Preferred Stock | I | -8 127 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -222 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | -34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 81 | 4 507 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 398 | 4 426 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 222 | 0 | 4 028 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 34 | 0 | 3 806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 34 | 0 | 3 806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-2 Preferred Stock | D | -3 010 807 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-1 Preferred Stock | D | -809 584 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series C Preferred Stock | D | -340 509 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series B Preferred Stock | D | -109 879 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -43 704 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -14 005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | -14 005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 10,0000 | 28 000 | 280 | 414 211 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 147 588 | 386 211 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 39 685 | 238 623 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 96 294 | 198 938 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 30 930 | 102 644 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 43 704 | 9 | 71 714 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 14 005 | 3 | 28 010 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 14 005 | 3 | 28 010 | ||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6 216 | ||||||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6 216 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33 950 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33 950 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1 470 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1 470 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17 900 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17 900 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
